Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment.
Saved in:
| Title: | Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment. |
|---|---|
| Authors: | Symington, Emily1 (AUTHOR) emily.symington1@nhs.net, Rangarajan, Savita2 (AUTHOR), Lester, Will3 (AUTHOR), Madan, Bella4 (AUTHOR), Pierce, Glenn F.5 (AUTHOR), Raheja, Priyanka6 (AUTHOR), Robinson, Tara M.7 (AUTHOR), Osmond, Dane7 (AUTHOR), Russell, Chris B.7 (AUTHOR), Vettermann, Christian7 (AUTHOR), Agarwal, Suresh K.7 (AUTHOR), Li, Mingjin7 (AUTHOR), Wong, Wing Yen7 (AUTHOR), Laffan, Michael8 (AUTHOR) |
| Source: | Haemophilia. Mar2024, Vol. 30 Issue 2, p320-330. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
